You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Aminocaproic acid - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for aminocaproic acid and what is the scope of patent protection?

Aminocaproic acid is the generic ingredient in four branded drugs marketed by Clover Pharms, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Akorn, Amneal Pharms Llc, Vistapharm, Amneal, and Sunny Pharmtech Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for aminocaproic acid. Ten suppliers are listed for this compound.

Drug Prices for aminocaproic acid

See drug prices for aminocaproic acid

Recent Clinical Trials for aminocaproic acid

Identify potential brand extensions & 505(b)(2) entrants

Carlos A Acosta-OlivoPhase 2
Aswan University HospitalN/A
Bioverativ Therapeutics Inc.Early Phase 1

See all aminocaproic acid clinical trials

Pharmacology for aminocaproic acid
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Medical Subject Heading (MeSH) Categories for aminocaproic acid

US Patents and Regulatory Information for aminocaproic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clover Pharms AMICAR aminocaproic acid TABLET;ORAL 015197-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Sunny Pharmtech Inc AMINOCAPROIC ACID aminocaproic acid TABLET;ORAL 209060-002 Nov 27, 2018 AB RX No Yes   Start Trial   Start Trial   Start Trial
Vistapharm AMINOCAPROIC ACID aminocaproic acid SYRUP;ORAL 212814-001 Feb 26, 2020 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.